Form D · Biotechnology
Metanoia Bio Inc
Lewes, DE · CIK 0002121615
Offering snapshot reported Mar 18, 2026 · SEC filing
- Reported sold
- $900K Offering amount: $5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Mar 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2026 | Initial | $900,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-576942
Option to raise up to $7.5m
Source: Form D, filed Mar 18, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brent Cohen | Director, Executive, Promoter |
| Oppel Greeff | Director, Promoter |
| Hilton Mendelsohn | Promoter |
| Slavica Tudzarova | Promoter |
| Abraham Van Wyk | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
16192 Coastal Highway ,
Lewes, DE, 19958
Lewes, DE, 19958